title: Evidence of comparative efficacy should have a formal role in European drug approvals.
authors: LSE Health and Social Care, London School of Economics and Political Science, London WC2A 2AE, UK.
authors: Corinna
authors: C
authors: Sorenson
authors: Huseyin
authors: H
authors: Naci
authors: Jonathan
authors: J
authors: Cylus
authors: Elias
authors: E
authors: Mossialos
mesh_terms: D017277:Drug Approval / Q000379:methods*; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D005060:Europe; D040541:Marketing